Anavex Life Sciences

Anavex Life Sciences Corp. (NASDAQ: AVXL) is a clinical stage biopharmaceutical company that focuses on the development of drugs to treat Alzheimer's CNS diseases and other types of cancer which have significant unmet medical needs. According to GeoInvesting, Anavex is merely a "penny...

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL), a clinical-stage biopharmaceutical company that focuses on therapies for Alzheimer's Disease, were trading higher by more than 5 percent Thursday morning - only to give up gains and trade flat by the afternoon. Investors and traders were...

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) plummeted more than 14 percent on Tuesday. Anavex Life Sciences disclosed earlier in the day an SEC subpoena and formal investigation in a 10-K filing, which may be related to unusual activity in the company's stock. "On...